Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements and Hierarchy (Tables)

v3.22.2.2
Fair Value Measurements and Hierarchy (Tables)
12 Months Ended
Dec. 31, 2021
Class of Warrant or Right [Line Items]  
Schedule of carrying amounts of financial instruments

Successor

Predecessor

December 31, 

December 31, 

    

2021

  

  

2020

Financial Assets:

 

  

 

  

Cash

$

140,477,586

$

36,261,104

Restricted Cash

$

356,286

$

3,641,843

Clinics Fees and Insurance Receivables, Net

$

1,090,104

$

675,954

Other Receivables

$

726,903

$

146,117

Financial Liabilities:

 

  

 

  

Accounts Payable and Accrued Expenses

$

17,730,683

$

11,793,125

Liability for Warrants

$

11,382,826

$

6,316,605

Summary of changes in company's Level 3 fair value measurements

    

Successor

 

  

Predecessor

   

December 3, 2021

  

  

    

through

Year

December 31,

January 1, 2021

Ended

2021

through

December

(Private

December 2, 2021

31, 2020

Placement

(Class D

(Class D

Warrants)

Warrants)

Warrants)

Beginning Balance

$

793,650

$

6,316,605

$

N/A

Issuance of Class D Warrants

6,316,605

Mark-to-Market Adjustment for Stock Warrants

 

(291,374)

 

7,664,869

 

Ending Balance

$

502,276

$

13,981,474

$

6,316,605

Class D Warrants  
Class of Warrant or Right [Line Items]  
Summary of Level 3 inputs into option pricing model

Volatility

    

65.0

%

Risk-Free Interest rate

 

0.10

%

Exercise Price

$

4.68

Expected Term

 

1.1

Years

Private Placement Warrants  
Class of Warrant or Right [Line Items]  
Summary of Level 3 inputs into option pricing model

Volatility

    

60.0

%  

Risk-Free Interest rate

 

1.26

%  

Exercise Price

$

11.50

 

Expected Term

 

4.9

Years